New Discoveries and Honors in Cancer Research

Read the latest cancer research and recognition from the members of the Damon Runyon scientific circle.
January 20, 2016
Biomarker predicts which colon cancer patients may benefit from chemotherapy

Piero D. Dalerba, MD (Damon Runyon-Rachleff Innovator ‘16-‘17), of Columbia University Medical Center, New York, and colleagues, have identified a biomarker, the CDX2 gene, that could be used to predict which stage II colon cancer patients may benefit from chemotherapy after surgery to prevent a recurrence of their disease. They found that cancers that do not express the gene have a worse prognosis than those that do. The study was published in the online edition of the New England Journal of Medicine.